文献速递免疫规划传染病防控与疫情报告

Rev1Δwzm候选疫苗在幼年和成年绵羊中安全,并保护公羊抵抗绵羊种布鲁氏菌感染

Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams.
PubMed 文献 · Vaccine · 2024-05-27

本研究评估了布鲁氏菌Rev1Δwzm候选疫苗在幼年和成年绵羊中的安全性、血清学反应及对绵羊种布鲁氏菌(B. ovis)的攻击保护。结果显示该疫苗安全,仅≤50%绵羊出现短暂玫瑰 Bengal 试验阳性,并诱导更强的抗粗糙型LPS反应,免疫25周后保护公羊抵抗B. ovis攻击;作者认为其是有前景的Rev1替代候选,但需进一步评估对孕羊B. melitensis的效力。

要点

  • Rev1Δwzm在幼年和成年绵羊(雌雄)中安全。
  • ≤50%绵羊出现短暂玫瑰Bengal试验阳性,抗粗糙型LPS反应更强更持久。
  • 免疫25周后保护公羊抵抗B. ovis攻击。

核心结论

  • Rev1Δwzm在幼年和成年绵羊中安全,并保护公羊抵抗B. ovis攻击,结合孕羊安全性数据,作者认为其是坚实的候选疫苗和Rev1的有前景替代。
  • 作者指出需进一步实验评估其对孕羊B. melitensis的效力。

研究设计与样本

  • 研究评估Rev1Δwzm在幼年和成年绵羊(雌雄)中的安全性、血清学反应及对公羊B. ovis攻击的保护。

主要发现

  • Rev1Δwzm在幼年和成年绵羊(雌雄)中安全。
  • ≤50%绵羊出现短暂玫瑰Bengal试验血清学反应,补体结合试验一定程度上确认,并诱导更强更持久的抗粗糙型LPS反应。
  • 免疫25周后保护公羊抵抗B. ovis攻击。
  • 使用绿色荧光蛋白标记策略可通过单次接种识别免疫绵羊。

局限性

  • 需进一步实验评估对孕羊B. melitensis的效力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small ruminants affected by brucellosis, caused mainly by Brucella melitensis and B. ovis, suffer reproductive disorders, leading to significant economic losses worldwide. Vaccination is an essential tool to prevent the disease in ovine and caprine livestock, but the only vaccine recommended to date is B. melitensis Rev1, which in sheep is only safe for use in lambs aged 3-4 months. This restriction poses considerable practical challenges for the implementation of Rev1 in countries with endemic brucellosis and/or limited resources, where there is a need for mass vaccination with a safe vaccine to control the disease in both animals and humans. We recently developed a B. melitensis strain Rev1Δwzm showing superior vaccine properties in mice and safety in pregnant ewes. Here, we report that Rev1Δwzm (i) is safe in young and adult sheep, both male and female; (ii) induces a transient serological response in the Rose Bengal test in ≤50 % of sheep, confirmed to some extent by the complement fixation test, and a stronger, more persistent anti- rough-LPS response; and (iii) protects rams against a B. ovis challenge 25 weeks after vaccination. To resolve the problem of serological interference, the use of green fluorescent protein tagging strategy allowed us to identify vaccinated sheep with only a single inoculation. These results, together with the previously reported safety in pregnant ewes, position Rev1Δwzm as a firm vaccine candidate and a promising alternative to Rev1. Further experiments are warranted to assess its efficacy against B. melitensis in pregnant ewes.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mena-Bueno S, Garrido V, Romero F, et al. Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams. Vaccine. 2024. PMID: 38806353. doi:10.1016/j.vaccine.2024.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。